These findings support the tumor-intrinsic role of several RNA modification regulators in bladder cancer while also implicating IGF2BP2 and TRDMT1 in stromal remodeling and tumor–stroma interactions. This evidence concerns the gene IGF2BP2 and urinary bladder carcinoma.